Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

2.

The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.

Foster SA, Parker S, Lanier R.

Viruses. 2017 Oct 30;9(11). pii: E320. doi: 10.3390/v9110320.

3.

Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.

Feldman SR, Foster SA, Zhu B, Burge R, Al Sawah S, Goldblum OM.

J Drugs Dermatol. 2017 Dec 1;16(12):1246-1252.

PMID:
29240860
4.

Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis.

Al Sawah S, Foster SA, Burge R, Amato D, Schacht A, Zhu B, Hartz S, Leonardi C.

J Med Econ. 2017 Dec;20(12):1224-1230. doi: 10.1080/13696998.2017.1362413. Epub 2017 Aug 22.

PMID:
28760056
5.

Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches.

Foster SA, Klijn C, Malek S.

Trends Cancer. 2016 Dec;2(12):699-701. doi: 10.1016/j.trecan.2016.10.015. Epub 2016 Nov 21.

PMID:
28741516
6.

Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.

Al Sawah S, Foster SA, Goldblum OM, Malatestinic WN, Zhu B, Shi N, Song X, Feldman SR.

J Med Econ. 2017 Sep;20(9):982-990. doi: 10.1080/13696998.2017.1345749. Epub 2017 Jul 11.

PMID:
28635342
7.

Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.

Grossi IM, Foster SA, Gainey MR, Krile RT, Dunn JA, Brundage T, Khouri JM.

Antiviral Res. 2017 Jul;143:278-286. doi: 10.1016/j.antiviral.2017.04.002. Epub 2017 Apr 7.

PMID:
28392420
8.

The RAS/MAPK Axis Gets Stressed Out.

Foster SA, Malek S.

Mol Cell. 2016 Dec 1;64(5):854-855. doi: 10.1016/j.molcel.2016.11.024.

9.

Assessment of novel digital and smartphone goniometers for measurement of canine stifle joint angles.

Freund KA, Kieves NR, Hart JL, Foster SA, Jeffery U, Duerr FM.

Am J Vet Res. 2016 Jul;77(7):749-55. doi: 10.2460/ajvr.77.7.749.

PMID:
27347828
10.

The caregiver burden in lupus: findings from UNVEIL, a national online lupus survey in the United States.

Al Sawah S, Daly RP, Foster SA, Naegeli AN, Benjamin K, Doll H, Bond G, Moshkovich O, Alarcón GS.

Lupus. 2017 Jan;26(1):54-61. Epub 2016 May 28.

PMID:
27235701
11.

Is neighbourhood access to tobacco outlets related to smoking behaviour and tobacco-related health outcomes and hospital admissions?

Barnes R, Foster SA, Pereira G, Villanueva K, Wood L.

Prev Med. 2016 Jul;88:218-23. doi: 10.1016/j.ypmed.2016.05.003. Epub 2016 May 3.

PMID:
27154350
12.

Acute systemic DNA damage in youth does not impair immune defense with aging.

Pugh JL, Foster SA, Sukhina AS, Petravic J, Uhrlaub JL, Padilla-Torres J, Hayashi T, Nakachi K, Smithey MJ, Nikolich-Žugich J.

Aging Cell. 2016 Aug;15(4):686-93. doi: 10.1111/acel.12478. Epub 2016 Apr 13.

13.

Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis.

Foster SA, Zhu B, Guo J, Nikai E, Ojeh C, Malatestinic W, Goldblum O, Kornberg LJ, Wu JJ.

J Manag Care Spec Pharm. 2016 Apr;22(4):396-405. doi: 10.18553/jmcp.2016.22.4.396.

14.

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2.

Foster SA, Whalen DM, Özen A, Wongchenko MJ, Yin J, Yen I, Schaefer G, Mayfield JD, Chmielecki J, Stephens PJ, Albacker LA, Yan Y, Song K, Hatzivassiliou G, Eigenbrot C, Yu C, Shaw AS, Manning G, Skelton NJ, Hymowitz SG, Malek S.

Cancer Cell. 2016 Apr 11;29(4):477-493. doi: 10.1016/j.ccell.2016.02.010. Epub 2016 Mar 17.

15.

Life-history plasticity in female threespine stickleback.

Baker JA, Wund MA, Heins DC, King RW, Reyes ML, Foster SA.

Heredity (Edinb). 2015 Oct;115(4):322-34. doi: 10.1038/hdy.2015.65. Epub 2015 Aug 19. Review.

16.
17.

Iterative development and the scope for plasticity: contrasts among trait categories in an adaptive radiation.

Foster SA, Wund MA, Graham MA, Earley RL, Gardiner R, Kearns T, Baker JA.

Heredity (Edinb). 2015 Oct;115(4):335-48. doi: 10.1038/hdy.2015.66. Epub 2015 Aug 5. Review.

18.

Evolutionary Influences of Plastic Behavioral Responses Upon Environmental Challenges in an Adaptive Radiation.

Foster SA, Wund MA, Baker JA.

Integr Comp Biol. 2015 Sep;55(3):406-17. doi: 10.1093/icb/icv083. Epub 2015 Jul 10. Review.

19.

Effects of Obesity on Health Related Quality of Life Following Total Hip Arthroplasty.

Foster SA, Hambright DS, Antoci V, Greene ME, Malchau H, Kwon YM.

J Arthroplasty. 2015 Sep;30(9):1551-4. doi: 10.1016/j.arth.2015.03.023. Epub 2015 Mar 31.

PMID:
25887700
20.

Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort.

Al Sawah S, Zhang X, Zhu B, Magder LS, Foster SA, Iikuni N, Petri M.

Lupus Sci Med. 2015 Mar 11;2(1):e000066. doi: 10.1136/lupus-2014-000066. eCollection 2015.

21.

The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease.

Trost LC, Rose ML, Khouri J, Keilholz L, Long J, Godin SJ, Foster SA.

Antiviral Res. 2015 May;117:115-21. doi: 10.1016/j.antiviral.2015.02.007. Epub 2015 Mar 4.

22.

The Effect of the Social and Physical Environment on Children's Independent Mobility to Neighborhood Destinations.

Christian HE, Klinker CD, Villanueva K, Knuiman MW, Foster SA, Zubrick SR, Divitini M, Wood L, Giles-Corti B.

J Phys Act Health. 2015 Jun 16;12 Suppl 1:S84-93. doi: 10.1123/jpah.2014-0271.

PMID:
25599389
23.

Multiple mechanisms determine the order of APC/C substrate degradation in mitosis.

Lu D, Hsiao JY, Davey NE, Van Voorhis VA, Foster SA, Tang C, Morgan DO.

J Cell Biol. 2014 Oct 13;207(1):23-39. doi: 10.1083/jcb.201402041. Epub 2014 Oct 6.

24.

A longitudinal analysis of the influence of the neighborhood built environment on walking for transportation: the RESIDE study.

Knuiman MW, Christian HE, Divitini ML, Foster SA, Bull FC, Badland HM, Giles-Corti B.

Am J Epidemiol. 2014 Sep 1;180(5):453-61. doi: 10.1093/aje/kwu171. Epub 2014 Aug 11.

PMID:
25117660
25.

Knuiman et al. respond to "Time-varying neighborhood environments".

Knuiman MW, Christian HE, Divitini ML, Foster SA, Bull FC, Badland HM, Giles-Corti B.

Am J Epidemiol. 2014 Sep 1;180(5):467-8. doi: 10.1093/aje/kwu172. Epub 2014 Aug 11. No abstract available.

PMID:
25117658
26.

Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey.

Foster SA, Shortridge EF, DiBonaventura M, Viktrup L.

World J Urol. 2015 May;33(5):639-47. doi: 10.1007/s00345-014-1366-6. Epub 2014 Aug 7.

PMID:
25100623
27.

Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups.

Johns BA, Kawasuji T, Weatherhead JG, Boros EE, Thompson JB, Koble CS, Garvey EP, Foster SA, Jeffrey JL, Fujiwara T.

Bioorg Med Chem Lett. 2014 Jul 15;24(14):3104-7. doi: 10.1016/j.bmcl.2014.05.011. Epub 2014 May 16.

PMID:
24908608
28.

Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: analysis of US National Health and Wellness Survey.

Foster SA, Annunziata K, Shortridge EF, Freedman D, Viktrup L.

Curr Med Res Opin. 2013 Dec;29(12):1709-17. doi: 10.1185/03007995.2013.837385. Epub 2013 Sep 23.

PMID:
23971532
29.

Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).

Johns BA, Kawasuji T, Weatherhead JG, Taishi T, Temelkoff DP, Yoshida H, Akiyama T, Taoda Y, Murai H, Kiyama R, Fuji M, Tanimoto N, Jeffrey J, Foster SA, Yoshinaga T, Seki T, Kobayashi M, Sato A, Johnson MN, Garvey EP, Fujiwara T.

J Med Chem. 2013 Jul 25;56(14):5901-16. doi: 10.1021/jm400645w. Epub 2013 Jul 11.

PMID:
23845180
30.

Reproductive success in a natural population of male three-spined stickleback Gasterosteus aculeatus: effects of nuptial colour, parasites and body size.

Sparkes TC, Rush V, Kopp DA, Foster SA.

J Fish Biol. 2013 May;82(5):1720-7. doi: 10.1111/jfb.12083. Epub 2013 Mar 27.

PMID:
23639166
31.

Osteoporosis and treatments in Japan: management for preventing subsequent fractures.

Nojiri S, Burge RT, Flynn JA, Foster SA, Sowa H.

J Bone Miner Metab. 2013 Jul;31(4):367-80. doi: 10.1007/s00774-013-0444-y. Epub 2013 Mar 28. Review.

PMID:
23536192
32.

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis.

Foster SA, Shi N, Curkendall S, Stock J, Chu BC, Burge R, Diakun DR, Krege JH.

BMC Womens Health. 2013 Mar 23;13:15. doi: 10.1186/1472-6874-13-15.

33.

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.

Hazel-Fernandez L, Louder AM, Foster SA, Uribe CL, Burge RT.

BMC Musculoskelet Disord. 2013 Jan 3;14:4. doi: 10.1186/1471-2474-14-4.

34.

Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groups.

Johns BA, Kawasuji T, Weatherhead JG, Boros EE, Thompson JB, Koble CS, Garvey EP, Foster SA, Jeffrey JL, Fujiwara T.

Bioorg Med Chem Lett. 2013 Jan 15;23(2):422-5. doi: 10.1016/j.bmcl.2012.11.071. Epub 2012 Dec 3.

PMID:
23245515
35.

The APC/C subunit Mnd2/Apc15 promotes Cdc20 autoubiquitination and spindle assembly checkpoint inactivation.

Foster SA, Morgan DO.

Mol Cell. 2012 Sep 28;47(6):921-32. doi: 10.1016/j.molcel.2012.07.031. Epub 2012 Aug 30.

36.

Budget impact analysis of insulin therapies and associated delivery systems.

Lee LJ, Smolen LJ, Klein TM, Foster SA, Whiteman D, Jorgenson JA, Hultgren S.

Am J Health Syst Pharm. 2012 Jun 1;69(11):958-65. doi: 10.2146/ajhp110333.

PMID:
22610028
37.

Preadmission glycemic control and changes to diabetes mellitus treatment regimen after hospitalization.

Bergenstal RM, Fahrbach JL, Iorga ŞR, Fan Y, Foster SA.

Endocr Pract. 2012 May-Jun;18(3):371-5. doi: 10.4158/EP11166.OR.

PMID:
22548941
38.

The impact of teriparatide adherence and persistence on fracture outcomes.

Yu S, Burge RT, Foster SA, Gelwicks S, Meadows ES.

Osteoporos Int. 2012 Mar;23(3):1103-13. doi: 10.1007/s00198-011-1843-3. Epub 2011 Dec 8.

PMID:
22159748
39.

Ubiquitination of Cdc20 by the APC occurs through an intramolecular mechanism.

Foe IT, Foster SA, Cheung SK, DeLuca SZ, Morgan DO, Toczyski DP.

Curr Biol. 2011 Nov 22;21(22):1870-7. doi: 10.1016/j.cub.2011.09.051. Epub 2011 Nov 10.

40.

Combining symmetry elements results in potent naphthyridinone (NTD) HIV-1 integrase inhibitors.

Johns BA, Kawasuji T, Weatherhead JG, Boros EE, Thompson JB, Garvey EP, Foster SA, Jeffrey JL, Miller WH, Kurose N, Matsumura K, Fujiwara T.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6461-4. doi: 10.1016/j.bmcl.2011.08.082. Epub 2011 Sep 8.

PMID:
21945283
41.

Rapid shifts in multiple life history traits in a population of threespine stickleback.

Baker JA, Heins DC, King RW, Foster SA.

J Evol Biol. 2011 Apr;24(4):863-70. doi: 10.1111/j.1420-9101.2010.02217.x. Epub 2011 Jan 31.

42.

In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor.

Kobayashi M, Yoshinaga T, Seki T, Wakasa-Morimoto C, Brown KW, Ferris R, Foster SA, Hazen RJ, Miki S, Suyama-Kagitani A, Kawauchi-Miki S, Taishi T, Kawasuji T, Johns BA, Underwood MR, Garvey EP, Sato A, Fujiwara T.

Antimicrob Agents Chemother. 2011 Feb;55(2):813-21. doi: 10.1128/AAC.01209-10. Epub 2010 Nov 29.

43.

Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitonin.

Foster SA, Whangbo A, Mitchell B, Muram D, Mershon JL, Kar R, Vedarajan G.

Curr Med Res Opin. 2010 Nov;26(11):2521-6. doi: 10.1185/03007995.2010.515456. Epub 2010 Sep 15.

PMID:
20843165
44.

Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance.

Foster SA, Foley KA, Meadows ES, Johnston JA, Wang SS, Pohl GM, Long SR.

Osteoporos Int. 2011 Feb;22(2):551-7. doi: 10.1007/s00198-010-1297-z. Epub 2010 Aug 27.

PMID:
20798929
45.

Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin.

Rodrigo-Brenni MC, Foster SA, Morgan DO.

Mol Cell. 2010 Aug 27;39(4):548-59. doi: 10.1016/j.molcel.2010.07.027.

46.

Predictors of initiating rapid-acting insulin analog using vial/syringe, prefilled pen, and reusable pen devices in patients with type 2 diabetes.

Lee LJ, Anderson J, Foster SA, Corrigan SM, Smith DM, Curkendall S.

J Diabetes Sci Technol. 2010 May 1;4(3):547-57.

47.

The nuts and bolts of subcutaneous insulin therapy in non-critical care hospital settings.

Juneja R, Foster SA, Whiteman D, Fahrbach JL.

Postgrad Med. 2010 Jan;122(1):153-62. doi: 10.3810/pgm.2010.01.2109. Review.

PMID:
20107299
48.

Relaxed selection in the wild.

Lahti DC, Johnson NA, Ajie BC, Otto SP, Hendry AP, Blumstein DT, Coss RG, Donohue K, Foster SA.

Trends Ecol Evol. 2009 Sep;24(9):487-96. doi: 10.1016/j.tree.2009.03.010. Epub 2009 Jun 6. Review.

PMID:
19500875
49.

Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo.

Goffinet C, Allespach I, Oberbremer L, Golden PL, Foster SA, Johns BA, Weatherhead JG, Novick SJ, Chiswell KE, Garvey EP, Keppler OT.

J Virol. 2009 Aug;83(15):7706-17. doi: 10.1128/JVI.00683-09. Epub 2009 May 20.

50.

Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.

Boros EE, Edwards CE, Foster SA, Fuji M, Fujiwara T, Garvey EP, Golden PL, Hazen RJ, Jeffrey JL, Johns BA, Kawasuji T, Kiyama R, Koble CS, Kurose N, Miller WH, Mote AL, Murai H, Sato A, Thompson JB, Woodward MC, Yoshinaga T.

J Med Chem. 2009 May 14;52(9):2754-61. doi: 10.1021/jm801404b.

PMID:
19374386

Supplemental Content

Loading ...
Support Center